| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.03T | 1.01T | 915.14B | 929.04B | 853.45B |
| Gross Profit | 390.76B | 395.51B | 330.86B | 337.44B | 302.39B |
| EBITDA | 257.09B | 262.50B | 202.04B | 209.19B | 185.70B |
| Net Income | 133.50B | 137.24B | 102.68B | 109.17B | 97.13B |
Balance Sheet | |||||
| Total Assets | 1.44T | 1.32T | 1.25T | 1.15T | 1.09T |
| Cash, Cash Equivalents and Short-Term Investments | 359.81B | 363.34B | 342.27B | 329.97B | 362.05B |
| Total Debt | 0.00 | 31.38B | 30.46B | 24.98B | 25.43B |
| Total Liabilities | 292.65B | 276.80B | 266.04B | 250.45B | 272.36B |
| Stockholders Equity | 1.15T | 1.04T | 984.02B | 902.21B | 821.19B |
Cash Flow | |||||
| Free Cash Flow | 95.58B | 111.91B | 87.75B | 115.78B | 85.53B |
| Operating Cash Flow | 192.18B | 217.91B | 155.52B | 181.70B | 144.49B |
| Investing Cash Flow | -107.44B | -115.11B | -67.93B | -159.91B | -57.59B |
| Financing Cash Flow | -106.60B | -78.89B | -90.78B | -57.63B | -36.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥326.69B | 5.46 | 9.34% | 4.27% | 0.43% | -23.12% | |
76 Outperform | ¥446.20B | 17.67 | 6.52% | 1.82% | 2.84% | 65.28% | |
72 Outperform | ¥1.93T | 18.54 | 11.98% | 1.54% | 1.41% | 0.76% | |
67 Neutral | ¥847.36B | 77.75 | -2.50% | 3.49% | -4.52% | -148.61% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥742.66B | 12.79 | 2.01% | 3.82% | -6.89% | -65.83% | |
58 Neutral | ¥1.18T | 9.28 | 3.63% | 3.98% | -0.42% | ― |